BOS 2023 - Manchester | BIO2BUSINESS | 27 November 2023 | Manchester Central, Windmill St, Manchester M2 3GX, UK
Venue
Manchester Central
Manchester Central, Windmill St, Manchester M2 3GX, UK
What is Qwoted?
Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
| Event Date |
Tue Nov 28 GMT - Wed Nov 29 GMT (about 1 year ago)
In your timezone (EST): Mon Nov 27 7:00pm - Tue Nov 28 7:00pm |
| Location |
Manchester Central
Windmill St, Manchester M2 3GX, UK |
| Region | EMEA |
Details
This events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. BOS is an event where business gets done and where you can be confident of high quality interactions with potential business partners. You will receive a warm welcome from the Bio2Business team in the vibrant and buzzing City of Manchester!
This event scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics and also covering Novel Therapeutic Entities.
Speakers
2023 Speakers
Dr Aleksandra Singh
R&D Oligonucleotide Synthesis Team Leader, Sixfold Bioscience
Miss Alissa Monk
Sustainability Lead, ten23 health
Mr Andrew Stark
Senior Scientist, Astrazeneca
Mr Anthony Fuller
Global Head of Sourcing, Mitsubishi Tanabe
Mr Calum Cook
Lead Technical Outsourcing Manager, AstraZeneca
Dr Colm Campbell
Senior Director, Chemical Development & Manufacturing, BioMarin
Mr Dr Vijayavitthal Mathad
Chief Operating Officer, CRAMSN Research Park Private Limited
Mr Duncan Judd
Director, Awridian Ltd
Dr Elizabeth Collins
Executive Director, Pharmaceutical Sciences, Pfizer
Dr Farid Khan
CEO, Pharmakure Ltd
Mr George Taylor
Chemistry Team Leader, Sai Life Sciences Limited
Dr Iain MacGilp
Senior Director, Curia Scotland Ltd
Dr Jan Haller
R&D-Chemist, Axplora
Dr Jenifer Mains
Director Formulation Science, Bicycle Therapeutics
Dr Joan Herbert
Vice President, Business Development, Medicines for Malaria Venture
Dr Kreshnik Hoxha
Director of CMC and Clinical Supply Chain, Grey Wolf Therapeutics
Dr Magdalena Kierkowicz
Senior Scientist, UCB Pharma Ltd
Dr. Mark Lawlor
Vice-President, Product Development, Pharmaron
Mr Mr Donald Charles Ross
Life Sciences Leader, CRAMSN Research Park Private Limited
Dr Paul Madeley
Managing Director, pmadeley@synthisis.com
Dr Paul Varley
VP CMC Development, Alchemab
Dr Paul Willis
Senior Director, MMV
Prof Scott Webster
Chief Technology Officer, Kynos Therapeutics Ltd
Dr Scott Wharry
Custom and Flow Chemistry Manager, Almac
Dr Shane McKenna
Principal Scientist, Bristol-Myers Squibb
Dr Stella James
Executive Director Business Development, Bionow
Mr Stephane Hauduc
Senior CMC Project and IP Manager, Destiny Pharma plc
Dr Suzanne Dilly
CEO, ValiRx PLC
Dr Thorsten Nowak
VP, Medicinal Chemistry, Exscientia
Dr Yogeshwar Bachhav
Associate Director (Consultant), AiCuris Anti-infective Cures AG
Sponsors & Partners
2023 Sponsors
GOLD SPONSORS:
• Almac Group
• Axplora
• CRAMSN Research Park Private Limited
• Curia
• Pharmaron
• Sai Life Sciences Limited
SILVER SPONSORS:
• Altasciences
• Ardena
• Catalent
• CordenPharma
• DIPHARMA FRANCIS
• Farmhispania Group
• Fermion Oy
• HAS Healthcare Advanced Synthesis SA
• Inaphaea BioLabs
• Laviana Pharma
• Lonza
• Olon SpA
• PROCOS S.P.A.
• Raybow Europe Incorporated ApS
• Solvias AG
• Syngene International Ltd.
• Vetter Pharma International GmbH
• Zach System SA
• Zasya Life Sciences Pvt. Ltd.